These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 387215)

  • 1. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma.
    Berd D; Wilson EJ; Bellet RE; Mastrangelo MJ
    Cancer Res; 1979 Nov; 39(11):4472-6. PubMed ID: 387215
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.
    Bruckner HW; Mokyr MB; Mitchell MS
    Cancer Res; 1974 Jan; 34(1):181-3. PubMed ID: 4588545
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
    Lohrmann HP; Lepp KA; Schreml W
    J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
    Brereton HD; Bryant TL; Young RC
    Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas.
    Hill HZ; Hill GJ; Miller CL; Pfaller M; Weiss K; Galin M
    Cancer Res; 1979 Mar; 39(3):934-9. PubMed ID: 427782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
    Dykes DJ; Griswold DP; Schabel FM
    Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial pulmonary fibrosis as a complication of prolonged methyl-CCNU therapy.
    Lee W; Moore RP; Wampler GL
    Cancer Treat Rep; 1978 Sep; 62(9):1355-8. PubMed ID: 688278
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
    Micetich KC; Jensen-Akula M; Mandard JC; Fisher RI
    Am J Med; 1981 Dec; 71(6):967-72. PubMed ID: 7032289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: acute leukemia after semustine (methyl-CCNU) therapy.
    Uphouse WJ; Oishi N
    Cancer Treat Rep; 1982 Jul; 66(7):1593-4. PubMed ID: 6953997
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.
    Boice JD; Greene MH; Killen JY; Ellenberg SS; Fraumeni JF; Keehn RJ; McFadden E; Chen TT; Stablein D
    N Engl J Med; 1986 Jan; 314(2):119-20. PubMed ID: 3941685
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation.
    Gast GC; The TH; Schraffordt Koops H; Snijder AM; Huiges HA
    Clin Exp Immunol; 1976 Mar; 23(3):491-8. PubMed ID: 947647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anticancer chemotherapeutic agents on immune reactions of mice. I. Comparison of two nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
    Ghaffar A; Lichter W; Wellham LL; Sigel MM
    J Natl Cancer Inst; 1978 Jun; 60(6):1483-7. PubMed ID: 650710
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
    Cohen MH; Schoenfeld D; Wolter J
    Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of the human immune response by cyclophosphamide.
    Berd D; Mastrangelo MJ; Engstrom PF; Paul A; Maguire H
    Cancer Res; 1982 Nov; 42(11):4862-6. PubMed ID: 7127320
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute leukemia after adjuvant therapy of gastrointestinal cancer with semustine (methyl-CCNU).
    N Engl J Med; 1984 Apr; 310(16):1057-8. PubMed ID: 6708984
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
    Twentyman PR
    Cancer Res; 1978 Aug; 38(8):2395-400. PubMed ID: 667838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.